1829P Exposure-safety analyses of talazoparib in combination of enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) in TALAPRO-2 trial
| Autor: | Azad, A.A., Wang, Y., Hadigol, M., Hoffman, J., Agarwal, N., Matsubara, N., Lincha, V.R., Zohren, F., DeAnnuntis, L., Wang, D. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S990-S990 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|